Information on admissions, scholarships, new courses, research studies and other events at schools and colleges ...

Sana Biotechnology, Inc. is a Strong Buy with promising cell therapies for diabetes & B-cell disorders. Click here to find ...

Biochemists study the molecular basis of life. This underpins our fundamental understanding of human health and disease and also supports applied science like drug discovery, diagnostics and ...

Oncolytics Biotech shares rose after the company said it will meet with the Food and Drug Administration in November about advancing its treatment for pancreatic cancer to a clinical trial. The stock ...

Genmab is continuing to build up its pipeline of wholly owned late-stage cancer assets, this time paying $8 billion for Netherlands-based Merus and its bispecific antibody. Analysts praised the ...

AstraZeneca has hailed another phase 3 win for its blood pressure drug candidate baxdrostat, boosting its attempts to turn the molecule’s long half-life into a competitive advantage. Baxdrostat, an ...

Spruce Bioscience (Nasdaq: SPRB) shares soared by 1,378% on Monday to $130.40 (£97). The stock is up another 82% during premarket hours on Tuesday. The monumental stock price jump in a single trading ...

Large corporations paid a combined $95.7 billion in income tax in the 2023 to 2024 financial year, the second biggest total ever recorded. Combined with takings from compliance programs, large ...

Artificial intelligence (AI) and machine learning are here to stay, so it’s crucial to understand how they can be used to the best effect in the evolving world of clinical trials. From patient ...

The treatment landscape of Inflammatory Bowel Disease (IBD) has undergone a significant transformation over the past two decades. Historically, therapeutic strategies primarily focused on suppressing ...

Our courses cover the full breadth of biology, from molecular and cell biology, genetics, development, human physiology and pharmacology through to evolution, ecology, biodiversity conservation and ...